Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesOccupational Exposure to Silica and Lung Cancer Risk in the Netherlands
Occupational and Environmental Medicine, 10/20/09
Preller L et al. – Adjusted for smoking and other confounders, elevated risks were observed for exposure duration and cumulative exposure. Associations with average exposure levels were weaker. Associations were stronger for occupations with an exposure probability of >= 90%. Adjustment for asbestos exposure slightly increased the risk. Results from this prospective population–based cohort study corroborates the classification of crystalline silica as lung carcinogen. Associations could not be explained by smoking or by asbestos exposure.
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Journal of Clinical Oncology, 11/05/09
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial
Lung Cancer, 11/03/09
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009
The Lancet Oncology, 11/02/09
Sponsor
Article Search
Sponsor
Sponsor